Cargando…

PARP inhibitor Olaparib increases the sensitization to radiotherapy in FaDu cells

Radioresistance causes a major problem for improvement of outcomes of patients treated with radiation. Targeting for DNA repair deficient mechanisms is a hallmark of sensitization to resistance. We tested whether Olaparib, a (poly) ADP‐ribose polymerase (PARP) inhibitor, can sensitize the radioresis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chuan, Gross, Neil, Li, Yanshi, Li, Guojun, Wang, Zhihai, Zhong, Shixun, Li, Yuncheng, Hu, Guohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028864/ https://www.ncbi.nlm.nih.gov/pubmed/31957270 http://dx.doi.org/10.1111/jcmm.14929

Ejemplares similares

Effect of celecoxib on inhibiting tumor repopulation during radiotherapy in human FaDu squamous cell carcinoma
por: Yang, Jia, et al.
Publicado: (2014)

Role and mechanism of Twist1 in modulating the chemosensitivity of FaDu cells
por: LU, SUMEI, et al.
Publicado: (2014)

The effect and mechanism of action of metformin on in vitro FaDu cell proliferation
por: Sun, Ruijie, et al.
Publicado: (2016)

Capsaicin-Induced Apoptosis of FaDu Human Pharyngeal Squamous Carcinoma Cells
por: Le, Thanh-Do, et al.
Publicado: (2012)

In vitro cytotoxicity of GO–DOx on FaDu squamous carcinoma cell lines
por: Singh, Manjri, et al.
Publicado: (2018)

Dasatinib worsens the effect of cetuximab in combination with fractionated radiotherapy in FaDu- and A431-derived xenografted tumours
por: Baro, M, et al.
Publicado: (2014)

Loss of NFBD1/MDC1 disrupts homologous recombination repair and sensitizes nasopharyngeal carcinoma cells to PARP inhibitors
por: Wang, Zhihai, et al.
Publicado: (2019)

The Limitations of Collagen/CPP Hybrid Peptides as Carriers for Cancer Drugs to FaDu Cells
por: Ho, Kevin, et al.
Publicado: (2019)

(+)-Usnic acid modulates the Nrf2-ARE pathway in FaDu hypopharyngeal carcinoma cells
por: Krajka-Kuźniak, Violetta, et al.
Publicado: (2021)

Arctigenin induces caspase-dependent apoptosis in FaDu human pharyngeal carcinoma cells
por: Kang, Kyeong-Rok, et al.
Publicado: (2022)

Influence of 2-Nitroimidazoles in the Response of FaDu Cells to Ionizing Radiation and Hypoxia/Reoxygenation Stress
por: Rashed, Faisal Bin, et al.
Publicado: (2023)

Downregulation of RNA binding motif protein 17 expression inhibits proliferation of hypopharyngeal carcinoma FaDu cells
por: Han, Yuefeng, et al.
Publicado: (2018)

Different levels of let-7d expression modulate response of FaDu cells to irradiation and chemotherapeutics
por: Lamperska, Katarzyna Monika, et al.
Publicado: (2017)

Simvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and Neck()
por: de Llobet, Lara I., et al.
Publicado: (2014)

Analysis of ceRNA network of differentially expressed genes in FaDu cell line and a cisplatin-resistant line derived from it
por: Zhang, Gehou, et al.
Publicado: (2021)

The use of matrigel has no influence on tumor development or PET imaging in FaDu human head and neck cancer xenografts
por: Fliedner, Frederikke P., et al.
Publicado: (2016)

Lovastatin causes FaDu hypopharyngeal carcinoma cell death via AMPK-p63-survivin signaling cascade
por: Yen, Chia-Sheng, et al.
Publicado: (2016)

Stathmin1 overexpression in hypopharyngeal squamous cell carcinoma: A new promoter in FaDu cell proliferation and migration
por: Chen, Yan, et al.
Publicado: (2016)

AGO2 involves the malignant phenotypes and FAK/PI3K/AKT signaling pathway in hypopharyngeal-derived FaDu cells
por: Zhang, Yanhui, et al.
Publicado: (2017)

PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation
por: Mao, Yize, et al.
Publicado: (2018)

Identification of Two New Phenanthrenes from Dendrobii Herba and Their Cytotoxicity towards Human Hypopharynx Squamous Carcinoma Cell (FaDu)
por: Nam, Bomi, et al.
Publicado: (2019)

Metformin Suppresses Hypopharyngeal Cancer Growth by Epigenetically Silencing Long Non-coding RNA SNHG7 in FaDu Cells
por: Wu, Ping, et al.
Publicado: (2019)

TBX3 knockdown suppresses the proliferation of hypopharyngeal carcinoma FaDu cells by inducing G1/S cell cycle arrest and apoptosis
por: Huang, Yongjiu, et al.
Publicado: (2020)

Demethoxycurcumin induces apoptosis via inhibition of NF-κB pathway in FaDu human head and neck squamous cell carcinoma
por: Lee, Gyeong-Je, et al.
Publicado: (2022)

Identification of differentially expressed genes associated with the enhancement of X-ray susceptibility by RITA in a hypopharyngeal squamous cell carcinoma cell line (FaDu)
por: Luan, Jinwei, et al.
Publicado: (2016)

Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment
por: Brú, Antonio, et al.
Publicado: (2009)

5-aza-2’-deoxycytidine induces apoptosis and inhibits tumour growth in vivo of FaDu cells, a specific HPVnegative HNSCC cell line
por: Miari, Reem, et al.
Publicado: (2021)

The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
por: Ordóñez, José Luis, et al.
Publicado: (2015)

Adenosine induces intrinsic apoptosis via the PI3K/Akt/mTOR signaling pathway in human pharyngeal squamous carcinoma FaDu cells
por: Choi, Mi Suk, et al.
Publicado: (2019)

ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib()
por: Wang, Chen, et al.
Publicado: (2017)

Rapamycin sensitizes cancer cells to growth inhibition by the PARP inhibitor olaparib
por: Osoegawa, Atsushi, et al.
Publicado: (2017)

Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
por: Ordóñez, José Luis, et al.
Publicado: (2017)

PARP inhibitor olaparib enhances the efficacy of radiotherapy on XRCC2-deficient colorectal cancer cells
por: Qin, Changjiang, et al.
Publicado: (2022)

PARP inhibitor olaparib sensitizes esophageal carcinoma cells to fractionated proton irradiation
por: Kageyama, Shun-ichiro, et al.
Publicado: (2020)

Erratum to "Capsaicin-Induced Apoptosis of FaDu Human Pharyngeal Squamous Carcinoma Cells" by Le TD, et al. (Yonsei Med J 2012;53:834-41.)
Publicado: (2012)

Recurrent Cervical Cancer Treated Successfully with Single-Agent PARP-Inhibitor, Olaparib
por: Gross, Maya, et al.
Publicado: (2022)

NVP-BEZ235, a dual PI3K-mTOR inhibitor, suppresses the growth of FaDu hypopharyngeal squamous cell carcinoma and has a synergistic effect with Cisplatin
por: Hsu, Cheng-Ming, et al.
Publicado: (2018)

Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib
por: de Haan, R., et al.
Publicado: (2019)

Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition
por: Cruz, Olga Villamar, et al.
Publicado: (2016)

JF-305, a pancreatic cancer cell line is highly sensitive to the PARP inhibitor olaparib
por: YANG, XUELI, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_isbuvqar7ogknee1aalrgb2qmn